Clinical Trial Update: Safety of ALK Ragweed Tablet [Phase 1]

View source ↗

Summary

A Phase 1 safety update reporting early safety findings for the ALK Ragweed Tablet in individuals with ragweed allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Ragweed Pollen Allergy

Drugs mentioned

• ALK Ragweed Tablet (ragweed pollen extract tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 1 | Status: COMPLETED